Methods and Applications of Statistics in Clinical Trials, Volume 1: Concepts, Principles, Trials, and Designs
by N. Balakrishnan
Chapter 47
Multiple Risk Factor Intervention Trial
47.1 Introduction
The Multiple Risk Factor Intervention Trial (MRFIT) was a nationwide randomized trial on primary prevention of coronary heart disease (CHD) death, sponsored by the National Heart, Lung, and Blood Institute within the United States National Institutes of Health, and it was conducted during 1972–1982. The study cohort consisted of men (baseline ages 35–57 years) at higher risk for CHD death, but with no clinical evidence of cardiovascular disease (CVD); women were not included because of substantially lower CHD rates. The intervention tested was multifactor: intensive counseling for smoking cessation, dietary advice particularly to lower serum cholesterol, and stepped-care pharmacologic treatment for hypertension (primarily with diuretics). The primary outcome was CHD mortality, with an observation period of 6 years minimum and 7 years on average [1,2]. Since the end of active follow-up in 1982, the 361,662 men who were screened during MRFIT recruitment, which includes the 12,866 who were randomized, have been followed for mortality date and cause through Social Security Administration and National Death Index searches [3,4].
47.2 Trial Design
47.2.1 Overview
The objective of MRFIT was to test whether a multifactor intervention would result in lower CHD mortality among men, baseline ages 35–57 years, at higher risk for CHD as measured by three ...
Become an O’Reilly member and get unlimited access to this title plus top books and audiobooks from O’Reilly and nearly 200 top publishers, thousands of courses curated by job role, 150+ live events each month,
and much more.
Read now
Unlock full access